BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21683840)

  • 1. Continued controversy regarding adverse events after Amplatzer septal device closure: mass hysteria or tip of the iceberg?
    DiBardino DJ; Mayer JE
    J Thorac Cardiovasc Surg; 2011 Jul; 142(1):222-3. PubMed ID: 21683840
    [No Abstract]   [Full Text] [Related]  

  • 2. Late erosion of an Amplatzer septal occluder device 6 years after placement.
    Taggart NW; Dearani JA; Hagler DJ
    J Thorac Cardiovasc Surg; 2011 Jul; 142(1):221-2. PubMed ID: 21463878
    [No Abstract]   [Full Text] [Related]  

  • 3. Snares for embolized septal occluders: retrieval of tangled, twisted, and mangled devices in structural heart intervention.
    Feldman T
    Catheter Cardiovasc Interv; 2011 May; 77(6):901-2. PubMed ID: 21520388
    [No Abstract]   [Full Text] [Related]  

  • 4. Percutaneous retrieval of the locked helex septal occluder.
    Poommipanit P; Levi D; Shenoda M; Tobis J
    Catheter Cardiovasc Interv; 2011 May; 77(6):892-900. PubMed ID: 20853357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Very late patent foramen ovale occluder device embolization.
    Gaspardone A; Giardina A; Gioffrè G; Iamele M; Borioni R
    J Cardiovasc Med (Hagerstown); 2011 Apr; 12(4):282-4. PubMed ID: 21386687
    [No Abstract]   [Full Text] [Related]  

  • 6. Malpositioned PFO device repair after the fact. Percutaneously? Really?
    Butman SM
    Catheter Cardiovasc Interv; 2010 Apr; 75(5):782-3. PubMed ID: 20333774
    [No Abstract]   [Full Text] [Related]  

  • 7. Closing one hole leads to another: delayed aortic perforation following closure of a patent foramen ovale.
    Kimmelstiel C
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):135-6. PubMed ID: 20578219
    [No Abstract]   [Full Text] [Related]  

  • 8. Patent foramen ovale closure and subsequent atrial fibrillation.
    Tobis J
    Catheter Cardiovasc Interv; 2009 Nov; 74(6):896. PubMed ID: 19902510
    [No Abstract]   [Full Text] [Related]  

  • 9. Device closure of patent foramen ovale--do similar devices achieve similar results?
    Kimmelstiel C
    Catheter Cardiovasc Interv; 2011 Apr; 77(5):715. PubMed ID: 21433274
    [No Abstract]   [Full Text] [Related]  

  • 10. Nickel allergy and device closure of the patent foramen ovale, now that we were told should we care?
    Meier B
    Catheter Cardiovasc Interv; 2009 Oct; 74(4):652. PubMed ID: 19780059
    [No Abstract]   [Full Text] [Related]  

  • 11. Taming the "cobra": an approach to "cobra-like" formation seen in the Occlutech atrial septal defect and patent foramen ovale occluders.
    Aaron S; Mainzer G; Lorber A
    Catheter Cardiovasc Interv; 2012 Mar; 79(4):678-80. PubMed ID: 21805618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous closure of patent foramen ovale and the risk of atrial fibrillation.
    Bhindi R
    Catheter Cardiovasc Interv; 2010 Feb; 75(2):301; author reply 302. PubMed ID: 20049956
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term follow-up of the Starflex device for closure of secundum atrial septal defect.
    Tobis J
    Catheter Cardiovasc Interv; 2009 Feb; 73(2):196. PubMed ID: 19156889
    [No Abstract]   [Full Text] [Related]  

  • 14. Very late migration to and retrieval of an Amplatzer patent foramen ovale occlusion device from the abdominal aortic carrefour.
    Musuraca G; Agostoni P; Boldi E; Imperadore F; Terraneo C; Broso GP
    J Cardiovasc Med (Hagerstown); 2018 Aug; 19(8):459-461. PubMed ID: 29894354
    [No Abstract]   [Full Text] [Related]  

  • 15. Very late erosion of Amplatzer septal occluder device presenting as pericardial pain and effusion 8 years after placement.
    Roberts WT; Parmar J; Rajathurai T
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):E592-4. PubMed ID: 23172721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patent foramen ovale and migraine headaches: the saga continues.
    Tobis J
    Catheter Cardiovasc Interv; 2011 Mar; 77(4):575-6. PubMed ID: 21351232
    [No Abstract]   [Full Text] [Related]  

  • 17. New onset atrial fibrillation after patent foramen ovale closure.
    Staubach S; Steinberg DH; Zimmermann W; Wawra N; Wilson N; Wunderlich N; Sievert H
    Catheter Cardiovasc Interv; 2009 Nov; 74(6):889-95. PubMed ID: 19626689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interatrial shunt closure devices in patients with nickel allergy.
    Reddy BT; Patel JB; Powell DL; Michaels AD
    Catheter Cardiovasc Interv; 2009 Oct; 74(4):647-51. PubMed ID: 19777603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained long-term benefit of patent foramen ovale closure on migraine.
    Trabattoni D; Fabbiocchi F; Montorsi P; Galli S; Teruzzi G; Grancini L; Gatto P; Bartorelli AL
    Catheter Cardiovasc Interv; 2011 Mar; 77(4):570-4. PubMed ID: 21351231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous device closure of congenital and iatrogenic ventricular septal defects in adult patients.
    Al-Kashkari W; Balan P; Kavinsky CJ; Cao QL; Hijazi ZM
    Catheter Cardiovasc Interv; 2011 Feb; 77(2):260-7. PubMed ID: 20853354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.